| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2010 | US20100184746 potent antimicrobial activity against macrolide resistant streptococcus pneumococci against which lincomycin and clindamycin are ineffective; therapeutic agents for infectious diseases in respiratory organs |
| 07/22/2010 | US20100184745 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 07/22/2010 | US20100184744 Method of preparing a pharmaceutical co-crystal composition |
| 07/22/2010 | US20100184743 Use of cholinesterase inhibitors for treating vascular depression |
| 07/22/2010 | US20100184742 Polymorphisms in abcb1 associated with a lack of clinical response to medicaments |
| 07/22/2010 | US20100184741 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/22/2010 | US20100184740 Substituted oxazolidinones and their use |
| 07/22/2010 | US20100184739 Modulators of ATP-Binding Cassette Transporters |
| 07/22/2010 | US20100184738 Uses of cinnoline compounds to treat schizophrenia |
| 07/22/2010 | US20100184737 Imidazole compounds for the treatment of neurological disorders |
| 07/22/2010 | US20100184736 Treatment of Meconium Aspiration Syndrome with Estrogens |
| 07/22/2010 | US20100184735 Locally active "soft" antiandrogens |
| 07/22/2010 | US20100184734 Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
| 07/22/2010 | US20100184733 Skin treatment composition |
| 07/22/2010 | US20100184732 Method of long-term treatment of graft-versus-host disease using topical active corticosteroids |
| 07/22/2010 | US20100184731 Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation |
| 07/22/2010 | US20100184730 Fatty Acid Acylated Salicylates and Their Uses |
| 07/22/2010 | US20100184729 New Pharmaceutical Compositions for Treatment of Thrombosis |
| 07/22/2010 | US20100184728 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
| 07/22/2010 | US20100184727 Treatment of excess sebum production |
| 07/22/2010 | US20100184725 Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin |
| 07/22/2010 | US20100184724 Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
| 07/22/2010 | US20100184723 Carbohydrate-lipid constructs and their use in preventing or treating viral infection |
| 07/22/2010 | US20100184722 Inclusion complexes of alpha-cyclodextrin and sildenafil salt |
| 07/22/2010 | US20100184721 Extract of Lentinus for Its Action on Cellulite and Accumulations of Fat |
| 07/22/2010 | US20100184720 Use of a natural polysaccharide gel for the preparation of an injectable formulation for treatment of articular degeneration |
| 07/22/2010 | US20100184719 Cetp inhibitors derived from benzoxazole arylamides |
| 07/22/2010 | US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells |
| 07/22/2010 | US20100184717 Treatment of Statin Side Effects Using Uridine Derivatives |
| 07/22/2010 | US20100184716 Pharmaceutical compositions with superior product performance and patient compliance |
| 07/22/2010 | US20100184715 Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 07/22/2010 | US20100184714 Compositions For Delivering A Drug |
| 07/22/2010 | US20100184712 Hyperbranched polymers based on cyclodextrins and poly (amidoamines) for the controlled release of insoluble drugs |
| 07/22/2010 | US20100184711 Alpha-GLYCOSYL THIOLS AND alpha-S-LINKED GLYCOLIPIDS |
| 07/22/2010 | US20100184710 Therapeutic Bifunctional Compounds |
| 07/22/2010 | US20100184707 Anticonvulsive pharmaceutical compositions |
| 07/22/2010 | US20100184691 Method for treating heart failure by inhibiting the sarcolemmal sodium/calcium exchange |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184688 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/22/2010 | US20100184670 Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis |
| 07/22/2010 | US20100184666 Novel use of cocoa extract |
| 07/22/2010 | US20100184665 Method for activating receptor by cofactor and method for utilizing ligand activity |
| 07/22/2010 | US20100184664 Ophthalmic compositions useful for improving visual acuity |
| 07/22/2010 | US20100184657 Methods of treating epithelial lesions outside the stomach and intestines |
| 07/22/2010 | US20100184650 Treating post-seizure patients |
| 07/22/2010 | US20100184648 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease |
| 07/22/2010 | US20100184643 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency |
| 07/22/2010 | US20100184607 Monosaccharide compounds and methods therefor |
| 07/22/2010 | US20100184207 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 07/22/2010 | US20100184084 Methods for measuring platelet reactivity of individuals treated with drug eluting stents |
| 07/22/2010 | US20100183774 Glucosamine as a food and beverage additive |
| 07/22/2010 | US20100183751 Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions |
| 07/22/2010 | US20100183749 Topically active steroids for use in radiation and chemotherapeutics injury |
| 07/22/2010 | US20100183743 Benzthiazole inhibitors of poly(adp-ribose)polymerase |
| 07/22/2010 | US20100183742 Phosphoramidate alkylator prodrugs for the treatment of cancer |
| 07/22/2010 | US20100183741 Dermatological compositions comprising at least one retinoid compound, an anti-irritant compound and benzoyl peroxide |
| 07/22/2010 | US20100183732 Novel one step process for preparing cross-linked poly(allylamine) polymers |
| 07/22/2010 | US20100183730 High dose composition of ursodeoxycholic acid |
| 07/22/2010 | US20100183729 Novel Process |
| 07/22/2010 | US20100183728 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 07/22/2010 | US20100183726 Compositions and methods for treating cancer with dacarbazine nanoemulsions |
| 07/22/2010 | US20100183725 Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 07/22/2010 | US20100183724 Hydrogel of Chitosan Carboxyalkylamide, Preparation Thereof and Cosmetic and Dermatological Use Thereof |
| 07/22/2010 | US20100183722 Modulation of proteases. particularly in the treatment of chronic ulcerous skin lesions |
| 07/22/2010 | US20100183721 Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
| 07/22/2010 | US20100183718 Compositions and treatment of heart deficiency in non-human animals |
| 07/22/2010 | US20100183717 Controlled-release formulations |
| 07/22/2010 | US20100183716 Tableted compositions containing atazanavir |
| 07/22/2010 | US20100183715 Tableted compositions containing atazanavir |
| 07/22/2010 | US20100183714 Gastroresistant pharmaceutical dosage form comprising n-(2-(2- phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423) |
| 07/22/2010 | US20100183713 Gastrointestinal-specific multiple drug release system |
| 07/22/2010 | US20100183712 Acylated indanyl amines and their use as pharmaceuticals |
| 07/22/2010 | US20100183711 Pharmaceutical compositions for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis |
| 07/22/2010 | US20100183710 Omeprazole form b |
| 07/22/2010 | US20100183707 Methods and compositions for treating hiv infection |
| 07/22/2010 | US20100183705 Phospholipid-analogous compounds |
| 07/22/2010 | US20100183704 dsRNA FOR TREATING VIRAL INFECTION |
| 07/22/2010 | US20100183702 Therapies For Cancer Using RLIP76 |
| 07/22/2010 | US20100183701 Wound Dressings comprising hydrated hydrogels and enzymes |
| 07/22/2010 | US20100183696 Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists |
| 07/22/2010 | US20100183692 compositions |
| 07/22/2010 | US20100183688 Delivery System and Method of Manufacturing the Same |
| 07/22/2010 | US20100183687 Process for preparing particles of opioids and compositions produced thereby |
| 07/22/2010 | US20100183677 Fusion proteins of mycobacterium tuberculosis |
| 07/22/2010 | US20100183666 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 07/22/2010 | US20100183665 Promoterless cassettes for expression of alpha virus structural proteins |
| 07/22/2010 | US20100183659 Allergen formulation |
| 07/22/2010 | US20100183658 Novel Compounds for Enhancing MHC Class II Therapies |
| 07/22/2010 | US20100183654 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 07/22/2010 | US20100183638 Restrictive agonist of toll-like receptor 3 (tlr3) |
| 07/22/2010 | US20100183637 fusion molecule based on novel taa variant |
| 07/22/2010 | US20100183634 Multifunctional nucleic acid nano-structures |
| 07/22/2010 | US20100183629 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 07/22/2010 | US20100183624 Methods for increasing adiponectin |
| 07/22/2010 | US20100183620 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2 |
| 07/22/2010 | US20100183613 Methods of using mevalonate decarboxylase (mvd) antagonists |
| 07/22/2010 | US20100183607 Risk markers for cardiovascular disease |
| 07/22/2010 | US20100183606 Monocyclic heterocycles as kinase inhibitors |
| 07/22/2010 | US20100183604 Preventive/remedy for cancer |
| 07/22/2010 | US20100183603 Compositions and Methods for the Treatment of Cancer |